Masimo Corporation experienced significant corporate transformations, including leadership changes following a high-profile proxy contest led by activist investors, resulting in the departure of its founder and the appointment of a new executive team. Alongside its internal boardroom shifts, the medical technology enterprise has been heavily engaged in high-stakes intellectual property litigation, particularly multi-year legal battles against consumer tech giant Apple concerning pulse oximetry and blood oxygen monitoring patents utilized in wearable devices.